Zane Ellen M, an insider at Boston Scientific Corp (BSX), sold 24,134 shares of the company on November 5, 2025, at a price of $98.28 per share, totaling $2.37 million. Following this transaction, Ellen retains 24,134 shares in the company.
Boston Scientific, headquartered in Marlborough, Massachusetts, is a leading developer and manufacturer of medical devices used in interventional procedures. The firm employs 53,000 full-time staff and operates within the health care industry. Its MedSurg segment includes Endoscopy, Urology, and Neuromodulation, focusing on less-invasive technologies for various medical conditions.
Insider selling can occur for a variety of reasons, such as diversification, tax planning, or personal financial needs. While significant sales may attract investor attention, they do not inherently reflect negative sentiment towards the company. It is crucial for investors to consider insider transactions in the context of broader market and company fundamentals.
Such decisions reflect individual circumstances rather than a definitive stance on the company’s prospects. Investors are encouraged to monitor patterns of insider trading across multiple executives and time periods to gain a more comprehensive view of insider sentiment.
Boston Scientific holds a market capitalization of $147.0 billion, with a price-to-earnings ratio of 52.65 and earnings per share of 1.87. Upcoming earnings are scheduled for April 20, 2026, with an estimated EPS of $0.79 and revenue of $5.3 billion.